{
    "clinical_study": {
        "@rank": "38411", 
        "arm_group": [
            {
                "arm_group_label": "PD", 
                "arm_group_type": "Active Comparator", 
                "description": "pneumodilation"
            }, 
            {
                "arm_group_label": "POEM", 
                "arm_group_type": "Active Comparator", 
                "description": "peroral endoscopic myotomy"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to compare the efficacy of per-oral endoscopic myotomy (POEM) to the\n      efficacy of pneumodilation as the initial treatment of symptomatic idiopathic achalasia. It\n      is hypothesized that POEM has a higher long-term efficacy than pneumodilation in treatment\n      of therapy-naive patients with idiopathic achalasia."
        }, 
        "brief_title": "POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)", 
        "completion_date": {
            "#text": "January 2023", 
            "@type": "Anticipated"
        }, 
        "condition": "Achalasia", 
        "condition_browse": {
            "mesh_term": "Esophageal Achalasia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Between 18 and 75 yr of age\n\n          -  Manometric diagnosis of achalasia\n\n          -  Eckardt score > 3\n\n          -  Informed consent\n\n        Exclusion Criteria:\n\n          -  Severe cardio-pulmonary disease or other serious disease leading to unacceptable\n             surgical risk previous treatment, except treatment with nitroderivatives, Ca++\n             channel blockers or sildenafil, or dilation with Savary bougies or balloons of 2 cm\n             diameter or smaller.\n\n        Pseudo-achalasia Mega-esophagus (> 7 cm) and/or sigmoid-like esophagus Previous esophageal\n        or gastric surgery (except for gastric perforation) Not capable to fill out questionnaires\n        (f.e. due to language barrier) Not available for follow-up Esophageal diverticula in the\n        distal esophagus Malignant or premalignant esophageal lesions Patients with liver\n        cirrhosis and/or esophageal varices Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01793922", 
            "org_study_id": "S55020"
        }, 
        "intervention": [
            {
                "arm_group_label": "PD", 
                "description": "pneumodilation", 
                "intervention_name": "PD", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "POEM", 
                "description": "peroral endoscopic myotomy", 
                "intervention_name": "POEM", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 10, 2013", 
        "location": {
            "contact": {
                "last_name": "A Moonen, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "zip": "3000"
                }, 
                "name": "UZ Leuven"
            }, 
            "investigator": {
                "last_name": "G Boeckxstaens, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Randomized Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM) as Treatment of Idiopathic Achalasia", 
        "overall_contact": {
            "email": "an.moonen@med.kuleuven.be", 
            "last_name": "G. Boeckxstaens, MD, PhD", 
            "phone": "016 34 28 65"
        }, 
        "overall_contact_backup": {
            "last_name": "A Moonen, MD"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: ethical committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The time till failure is the primary outcome parameter. The time is measured from date of pneumatic dilation (last session) or POEM to date of relapse of symptoms (date of establishment). Symptoms will be evaluated using the Eckardt scoring system (Table 1.). Therapeutic success is defined as a drop in Eckardt score to \u2264 3 after treatment and symptom control at yearly follow-up which is also defined as an Eckardt score of \u2264 3.\nIf symptoms recur within patients randomized for pneumatic dilation, retreatment with pneumatic dilation is allowed according to the protocol. If retreatment does not result in reduction of the symptom score below 4, the patient will be considered as a treatment failure.", 
            "measure": "therapeutic succes", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01793922"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Katholieke Universiteit Leuven", 
            "investigator_full_name": "Guy Boeckxstaens", 
            "investigator_title": "Prof. Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The quality of life is determined using a general QoL questionnaire, namely the SF36 questionnaire. In addition, a more disease specific questionnaire, i.e. the EORTC QLQ-OES24 questionnaire, is filled out. These questionnaires have scored the QoL at fixed time points during follow-up (1 month, 3 months and yearly).", 
                "measure": "quality of life", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Complications (perforation, bleeding, etc) occurring during or immediately following the procedure are recorded by the attending phycisian.\nIn addition, gastroesophageal reflux is measured using 24h pHmetry after 3 months and 1 year. The number of patients with pathological acid exposure (>4.5% of time a pH<4) will be assessed. Endoscopy is performed after 1 year to detect esophagitis. Esophagitis rates and LA grades of esophagitis will be assessed.", 
                "measure": "complication rate", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Retreatment is allowed in the pneumodilation group when symptoms recur, which is defined as an Eckardt score of > 3. Symptom scores are assessed after one month, three months and then yearly.", 
                "measure": "need for retreetment", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Katholieke Universiteit Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Katholieke Universiteit Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}